Abstract

218P Characteristics and outcomes of HER2-low (H-Low) and HER2-zero (H-0) advanced breast cancer (ABC) patients (pts) from GEICAM/2014-03 (RegistEM) registry

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The relationships among hope, optimism, attentional bias, cancer-related rumination and psychological distress in cancer patients
Suk-Mei, Damaris Hung
-
Suk-Mei, Damaris HungSuk-Mei, Damaris Hung
01 Jan 2010
The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients
Teguh Aryandono ... Yan Wisnu Prajoko
Asian Pacific Journal of Cancer Prevention | VOL. 20
Teguh Aryandono, et. al.Teguh Aryandono ... Yan Wisnu Prajoko
01 May 2019
Abstract P2-09-06: Safety and efficacy of stereotactic body radiotherapy and Pembrolizumab in advanced breast cancer patients with 1 to 5 metastases
Sp David ... P Savas
Cancer Research | VOL. 79
Sp David, et. al.Sp David ... P Savas
15 Feb 2019
Abstract P2-01-18: Orthogonal assessment of PIK3CA and ESR1 mutation detection in longitudinal cfDNA samples from endocrine-resistant HR+/HER2- advanced breast cancer patients using dPCR and NGS-based SafeSEQ technology
Hillary Sloane ... Fernando Moreno
Cancer Research | VOL. 82
Hillary Sloane, et. al.Hillary Sloane ... Fernando Moreno
15 Feb 2022
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents
Ruhee Jain ... Francesco De Solda
ESMO Open | VOL. 9
Ruhee Jain, et. al.Ruhee Jain ... Francesco De Solda
13 May 2024
Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial
Adrienne M Gilligan ... Luis E Raez
ESMO Open | VOL. 9
Adrienne M Gilligan, et. al.Adrienne M Gilligan ... Luis E Raez
01 May 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
Natalie Prinzi ... Sandra P D’Angelo
ESMO Open | VOL. 9
Natalie Prinzi, et. al.Natalie Prinzi ... Sandra P D’Angelo
01 May 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study
S.M.E Geurts ... K.B.M.I Keymeulen
ESMO Open | VOL. 9
S.M.E Geurts, et. al.S.M.E Geurts ... K.B.M.I Keymeulen
01 May 2024
View more papers